Skip to main content
Clinical Trials/JPRN-UMIN000024373
JPRN-UMIN000024373
Unknown
N/A

A study to evaluate pregnancy outcome and to establish a registration database of pregnant women with preexisting diabetes and Overt diabetes in pregnancy:a multicenter, prospective study -Diabetes and Pregnancy Outcome for Mother and Baby Study,DM and Overt DM-Pregnant Outcome study[DREAMBee study,DM/OvertDM-PO] - DREAMBee study[DM/OvertDM-PO]

The Japanese Society of Dianetes and Pregnancy0 sites135 target enrollmentOctober 12, 2016

Overview

Phase
N/A
Intervention
Not specified
Conditions
preexisting diabetes Overt diabetes in pregnancy
Sponsor
The Japanese Society of Dianetes and Pregnancy
Enrollment
135
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
October 12, 2016
End Date
December 31, 2031
Last Updated
2 years ago
Study Type
Observational
Sex
Female

Investigators

Sponsor
The Japanese Society of Dianetes and Pregnancy

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Not applicable

Outcomes

Primary Outcomes

Not specified

Similar Trials

Recruiting
N/A
Prospective study to evaluate the clinical outcome of POEM combined with endoscopic anti-reflux surgery.
JPRN-UMIN000028567Showa University Koto Toyosu Hospital100
Not Yet Recruiting
N/A
A preliminary study to evaluate effectiveness of Korean medicine treatment for periodontal disease
KCT0009294Dongguk University Ilsan Oriental Hospital45
Active, Not Recruiting
Phase 1
A Study of RoActemra/Actemra (tocilizumab) in Comparison to Enbrel (etanercept) in Patients With Rheumatoid Arthritis and Increased Risk for Heart Disease.Rheumatoid ArthritisMedDRA version: 14.0Level: PTClassification code 10039073Term: Rheumatoid arthritisSystem Organ Class: 10028395 - Musculoskeletal and connective tissue disordersTherapeutic area: Diseases [C] - Musculoskeletal Diseases [C05]
EUCTR2010-020065-24-ESF. Hoffmann-La Roche Ltd.2,800
Active, Not Recruiting
Phase 1
A Study of RoActemra/Actemra (tocilizumab) in Comparison to Enbrel (etanercept) in Patients With Rheumatoid Arthritis and Increased Risk for Heart Disease.Rheumatoid ArthritisMedDRA version: 16.1Level: PTClassification code 10039073Term: Rheumatoid arthritisSystem Organ Class: 10028395 - Musculoskeletal and connective tissue disordersTherapeutic area: Diseases [C] - Musculoskeletal Diseases [C05]
EUCTR2010-020065-24-BEF. Hoffmann-La Roche Ltd.3,080
Active, Not Recruiting
Phase 1
A Study of RoActemra/Actemra (tocilizumab) in Comparison to Enbrel (etanercept) in Patients With Rheumatoid Arthritis and Increased Risk for Heart Disease.Rheumatoid ArthritisMedDRA version: 14.0Level: PTClassification code 10039073Term: Rheumatoid arthritisSystem Organ Class: 10028395 - Musculoskeletal and connective tissue disordersTherapeutic area: Diseases [C] - Musculoskeletal Diseases [C05]
EUCTR2010-020065-24-GRF. Hoffmann-La Roche Ltd.2,800